Irene Dogliotti

636 total citations
32 papers, 165 citations indexed

About

Irene Dogliotti is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Irene Dogliotti has authored 32 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 14 papers in Hematology and 11 papers in Oncology. Recurrent topics in Irene Dogliotti's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Irene Dogliotti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Irene Dogliotti collaborates with scholars based in Italy, United States and Germany. Irene Dogliotti's co-authors include Simone Ferrero, Luisa Giaccone, Carmen Fava, Giuseppe Saglio, Daniela Drandi, Chiara Maria Dellacasa, Alessandro Busca, Giovanna Rege‐Cambrin, Elisa Genuardi and Roberto Passera and has published in prestigious journals such as Blood, Cancers and European Journal of Neurology.

In The Last Decade

Irene Dogliotti

26 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Dogliotti Italy 9 59 50 41 39 33 32 165
Kohmei Kubo Japan 9 68 1.2× 73 1.5× 24 0.6× 19 0.5× 29 0.9× 19 178
Vincenzo Cassibba Italy 6 77 1.3× 56 1.1× 36 0.9× 42 1.1× 43 1.3× 12 190
Mahsa Talbott United States 5 32 0.5× 40 0.8× 79 1.9× 61 1.6× 18 0.5× 10 141
Agnieszka Tomaszewska Poland 8 76 1.3× 38 0.8× 59 1.4× 52 1.3× 21 0.6× 27 194
Yotaro Ochi Japan 8 33 0.6× 46 0.9× 28 0.7× 46 1.2× 26 0.8× 23 161
Nobuya Hiraoka Japan 9 43 0.7× 74 1.5× 44 1.1× 72 1.8× 32 1.0× 22 254
Shunsuke Hatta Japan 9 46 0.8× 38 0.8× 39 1.0× 58 1.5× 16 0.5× 24 185
Tomoharu Takeoka Japan 7 29 0.5× 27 0.5× 25 0.6× 34 0.9× 28 0.8× 14 185
Juan Manuel Alonso‐Domínguez Spain 10 106 1.8× 58 1.2× 75 1.8× 26 0.7× 9 0.3× 40 242
Toyotaka Kawamata Japan 9 74 1.3× 37 0.7× 20 0.5× 17 0.4× 12 0.4× 30 244

Countries citing papers authored by Irene Dogliotti

Since Specialization
Citations

This map shows the geographic impact of Irene Dogliotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Dogliotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Dogliotti more than expected).

Fields of papers citing papers by Irene Dogliotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Dogliotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Dogliotti. The network helps show where Irene Dogliotti may publish in the future.

Co-authorship network of co-authors of Irene Dogliotti

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Dogliotti. A scholar is included among the top collaborators of Irene Dogliotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Dogliotti. Irene Dogliotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durot, Éric, Jithma P. Abeykoon, Damien Roos‐Weil, et al.. (2025). Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia. Seminars in Hematology. 62(2). 120–125. 1 indexed citations
2.
3.
Aydin, Semra, Jennifer Schmitz, Chiara Maria Dellacasa, et al.. (2024). WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients. Cancers. 16(17). 3070–3070. 1 indexed citations
4.
Dogliotti, Irene, Mario Levis, Sara Bartoncini, et al.. (2024). Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. Cancers. 16(5). 865–865. 4 indexed citations
5.
6.
Busca, Alessandro, Roberto Passera, Chiara Maria Dellacasa, et al.. (2023). Bacterial Bloodstream Infections after Allogeneic Hematopoietic Stem Cell Transplantation: Etiology, Risk Factors and Outcome in a Single-Center Study. Microorganisms. 11(3). 742–742. 14 indexed citations
7.
Shbaklo, Nour, Costanza Vicentini, Alessandro Busca, et al.. (2023). Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients. Pharmaceuticals. 16(3). 466–466. 5 indexed citations
8.
Aydin, Semra, Roberto Passera, Chiara Maria Dellacasa, et al.. (2022). Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia. International Journal of Hematology. 116(6). 883–891. 6 indexed citations
9.
Dogliotti, Irene, Davide Bertuzzo, Giulia Benevolo, et al.. (2022). Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. European Journal of Neurology. 29(12). 3611–3622. 9 indexed citations
10.
Dogliotti, Irene, Andrea Calcagno, Sarah Leone, et al.. (2021). COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment. HemaSphere. 5(7). e592–e592. 2 indexed citations
11.
Mondello, Patrizia, Caterina Musolino, Irene Dogliotti, et al.. (2020). ABVD vs BEACOPP escalated in advanced‐stage Hodgkin’s lymphoma: Results from a multicenter European study. American Journal of Hematology. 95(9). 1030–1037. 10 indexed citations
12.
Mondello, Patrizia, Irene Dogliotti, Federica Cavallo, et al.. (2019). ABVD Versus Escalated Beacopp in Advanced Stage Hodgkin's Lymphoma: Results from a Retrospective, Multicenter European Study. Blood. 134(Supplement_1). 1565–1565.
13.
Pott, Christiane, Henrik Knecht, Elisa Genuardi, et al.. (2017). Standardized IGH-Based Next-Generation Sequencing for MRD Detection in Follicular Lymphoma. Blood. 130. 1491–1491. 7 indexed citations
14.
Dogliotti, Irene, Carmen Fava, Anna Serra, et al.. (2017). CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report. PubMed. 4(7). 57–57. 12 indexed citations
15.
Dogliotti, Irene. (2017). PERSONALIZED MEDICINE IN LYMPHOMA: TAILORING TREATMENT ACCORDING TO MINIMAL RESIDUAL DISEASE. Medical Research Archives. 5(5). 3 indexed citations
16.
Fava, Carmen, Giovanna Rege‐Cambrin, Irene Dogliotti, et al.. (2016). Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor. Clinical Lymphoma Myeloma & Leukemia. 16. S96–S100. 9 indexed citations
17.
Vaccarino, A, et al.. (2016). Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy. Mediterranean Journal of Hematology and Infectious Diseases. 8. 2016050–2016050.
18.
Vaccarino, A, et al.. (2016). Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy. Mediterranean Journal of Hematology and Infectious Diseases. 8(1). e2016050–e2016050.
19.
Fava, Carmen, Enrico Gottardi, Paola Berchialla, et al.. (2015). COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4. Haematologica. 128–129. 1 indexed citations
20.
Fava, Carmen, Irene Dogliotti, Paola Berchialla, et al.. (2015). IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE. Haematologica. 100. 232–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kohmei Kubo Breakdown of academic impact, for papers by Vincenzo Cassibba Breakdown of academic impact, for papers by Mahsa Talbott Breakdown of academic impact, for papers by Agnieszka Tomaszewska Breakdown of academic impact, for papers by Yotaro Ochi Breakdown of academic impact, for papers by Nobuya Hiraoka Breakdown of academic impact, for papers by Shunsuke Hatta Breakdown of academic impact, for papers by Tomoharu Takeoka Breakdown of academic impact, for papers by Juan Manuel Alonso‐Domínguez Breakdown of academic impact, for papers by Toyotaka Kawamata
Rankless by CCL
2026